TRIFERON Trademark

Trademark Overview


On Friday, June 25, 1999, a trademark application was filed for TRIFERON with the United States Patent and Trademark Office. The USPTO has given the TRIFERON trademark a serial number of 75741619. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Wednesday, May 14, 2003. This trademark is owned by Human Genome Sciences, Inc.. The TRIFERON trademark is filed in the Pharmaceutical Products category with the following description:

Human interferon and pharmaceutical preparations containing interferon for the treatment of various (1) viral diseases, autoimmune diseases, and immunological disorders, namely, multiple sclerosis, HIV-AIDS, Hepatitis B and C, cancer, herpes, respiratory syncytial virus, pancricephalitis, and mycosis fungiodes; (2) cancers, namely, myclogenous leukemia, melanoina, renal carcinoma, colorectal cancer, cutaneous T cell lymphorna, myelodysplastic syndrome, glioma, head and neck cancer, breast cancer, gastric cancer and anti-cancer vaccine therapy; and (3) inflammatory responses, namely, infection and wound healing
triferon

General Information


Serial Number75741619
Word MarkTRIFERON
Filing DateFriday, June 25, 1999
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateWednesday, May 14, 2003
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 21, 2001

Trademark Statements


Goods and ServicesHuman interferon and pharmaceutical preparations containing interferon for the treatment of various (1) viral diseases, autoimmune diseases, and immunological disorders, namely, multiple sclerosis, HIV-AIDS, Hepatitis B and C, cancer, herpes, respiratory syncytial virus, pancricephalitis, and mycosis fungiodes; (2) cancers, namely, myclogenous leukemia, melanoina, renal carcinoma, colorectal cancer, cutaneous T cell lymphorna, myelodysplastic syndrome, glioma, head and neck cancer, breast cancer, gastric cancer and anti-cancer vaccine therapy; and (3) inflammatory responses, namely, infection and wound healing

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 15, 1999
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHuman Genome Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Party NameHuman Genome Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events


Event DateEvent Description
Thursday, January 8, 2004ABANDONMENT - NO USE STATEMENT FILED
Monday, January 13, 2003EXTENSION 2 GRANTED
Wednesday, November 13, 2002EXTENSION 2 FILED
Wednesday, November 13, 2002PAPER RECEIVED
Thursday, April 25, 2002EXTENSION 1 GRANTED
Tuesday, April 16, 2002EXTENSION 1 FILED
Tuesday, November 13, 2001NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 21, 2001PUBLISHED FOR OPPOSITION
Wednesday, August 1, 2001NOTICE OF PUBLICATION
Sunday, April 1, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 19, 2000CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 13, 2000CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 29, 1999REINSTATED
Monday, August 28, 2000ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, September 29, 1999NON-FINAL ACTION MAILED
Friday, September 24, 1999ASSIGNED TO EXAMINER